HomeACADEMIA
ACADEMIA

Use Patient Registries for Orphan, Intractable Diseases First: MHLW Study Group Chief
(May.9.2016)

Shinichi Takeda
The registry-based clinical development platform, dubbed “clinical innovation network (CIN),” should be built using patient registries in the clinical development of drugs for orphan and intractable diseases and then use this example as a model to expand its use into other fields, said Shinichi Takeda, director general of the National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), in a recent interview with Jiho ...
(LOG IN FOR FULL STORY)

News Calendar